BIOCAPTIVA Chair appointment to steer global growth
BIOCAPTIVA, a University of Edinburgh spin-out that develops advanced technologies to extract cell-free DNA (cfDNA) from blood for cancer liquid biopsies, has appointed experienced life sciences executive, Stephane Argivier as Chair to steer its next phase of international growth. The company’s patented msX platform has the potential to improve the… Read More